In addition, our analysis revealed that a higher CRBN serum ratio between LD initiation and BR (≥1.37) was significantly associated with anemia and earlier relapse to LD, suggesting that an increase in circulating CRBN may reflect disease progression or tumor stress. This evidence concerns the gene CRBN and anemia.